Literature DB >> 3558235

Mitigation of pulmonary hyperoxic injury by administration of exogenous surfactant.

S Matalon, B A Holm, R H Notter.   

Abstract

We studied the effects of surfactant supplementation on the progression of lung injury in rabbits exposed to 100% O2 for 64 h and returned to room air for 24 h. At this time, rabbits not treated with surfactant exhibit a severe lung injury with hypoxemia, increased alveolar premeability to solute, decreased total lung capacity (TLC) and lung edema. For surfactant treatment, 125 mg of calf lung surfactant extract (CLSE), suspended in 6-8 ml of normal saline, were instilled intratracheally at 0 and 12 h posthyperoxic exposure. At 24 h postexposure, these CLSE-treated rabbits compared with saline controls had significantly higher amounts of lung phospolipids (34 +/- 4 vs. 4.5 +/- 0.6 mumol/kg body wt) and increased TLC (42 +/- 2 vs. 27 +/- 1 ml/kg), with significantly lower amounts of alveolar protein (36 +/- 3 vs. 56 +/- 3 mg/kg) and decreased lung wet weight-to-dry weight ratios (5.6 +/- 0.1 vs. 6.3 +/- 0.3). Surfactant supplementation also decreased the degree of lung atelectasis as reflected by the increase in arterial O2 partial pressure (PaO2) after breathing 100% O2 for 20 min (PaO2 = 460 +/- 31 vs. 197 +/- 52 Torr). These findings indicate that instillation of exogenous surfactant mitigates the progression of hyperoxic lung injury in rabbits.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3558235     DOI: 10.1152/jappl.1987.62.2.756

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  14 in total

Review 1.  Calfactant: a review of its use in neonatal respiratory distress syndrome.

Authors:  S V Onrust; M Dooley; K L Goa
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1).

Authors:  Sotirios G Zarogiannis; James W Noah; Asta Jurkuvenaite; Chad Steele; Sadis Matalon; Diana L Noah
Journal:  Life Sci       Date:  2012-01-16       Impact factor: 5.037

3.  Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective.

Authors:  N S Morton
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

4.  Surfactant administration prior to one lung ventilation: physiological and inflammatory correlates in a piglet model.

Authors:  Rahul Bhatia; Thomas H Shaffer; Jobayer Hossain; Alicia Olivant Fisher; Liana M Horner; M Elena Rodriguez; Scott Penfil; Mary C Theroux
Journal:  Pediatr Pulmonol       Date:  2011-05-26

Review 5.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

6.  Ozone stress initiates acute perturbations of secreted surfactant membranes.

Authors:  J U Balis; J F Paterson; J M Lundh; E M Haller; S A Shelley; M R Montgomery
Journal:  Am J Pathol       Date:  1991-04       Impact factor: 4.307

7.  Effects of surfactant on lung injury induced by hyperoxia and mechanical ventilation in rabbits.

Authors:  J Ikegaki; K Mikawa; H Obara
Journal:  J Anesth       Date:  1993-01       Impact factor: 2.078

Review 8.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  Neonatal oxygen adversely affects lung function in adult mice without altering surfactant composition or activity.

Authors:  Min Yee; Patricia R Chess; Sharon A McGrath-Morrow; Zhengdong Wang; Robert Gelein; Rui Zhou; David A Dean; Robert H Notter; Michael A O'Reilly
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-17       Impact factor: 5.464

10.  Mitigation of chlorine-induced lung injury by low-molecular-weight antioxidants.

Authors:  Martin Leustik; Stephen Doran; Andreas Bracher; Shawn Williams; Giuseppe L Squadrito; Trenton R Schoeb; Edward Postlethwait; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-08-15       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.